03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Apo-Gabapentin : | |
Type | Medicine Authorised |
Originator | Neurontin 300mg* |
Agent | Promopharm |
Distributor | Promopharm |
Laboratory | Apotex |
Responsible Party | Apotex Inc |
Origin | Canada |
Manufacturer | Apotex Inc |
Manufacturing Type | G |
Origin | Canada |
ATC | N03AX12 |
Apo-Gabapentin :
Apo-Gabapentin :
Apo-Gabapentin :
Apo-Gabapentin :
Apo-Gabapentin :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Apo-Gabapentin :
Apo-Gabapentin :
Apo-Gabapentin :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Common |
Abrasion | Common |
Accidental injury | Common |
Acne | Common |
Aggressiveness | Common |
Allergic reaction | Uncommon |
Alopecia | Not known |
ALT increased | Uncommon |
Amblyopia | Common |
Amnesia | Common |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Not known |
Anorexia | Common |
Anorgasmia | Not known |
Anxiety | Common |
Arthralgia (Pain joint) (Joint ache) | Common |
AST increased | Uncommon |
Asthenia | Common |
Ataxia | Very Common |
Back pain | Common |
Blood bilirubin increased | Uncommon |
Blood creatine phosphokinase increased | Not known |
Bronchitis | Common |
Cephalea | Common |
Chest pain | Not known |
Choreoathetosis | Not known |
Confusion | Common |
Consciousness loss | Rare |
Constipation | Common |
Convulsion | Common |
Coordination disturbance | Common |
Cough | Common |
Depression | Common |
Diarrhoea (Diarrhea) | Common |
Diplopia | Common |
Dry mouth (Xerostomia) | Common |
Dry throat | Common |
Dysarthria | Common |
Dyskinesia | Not known |
Dyspepsia | Common |
Dyspnoea (dyspnea) | Common |
Dystonia | Not known |
Ejaculation disorder | Not known |
Emotional lability | Common |
Eosinophilia | Not known |
Erythema multiforme | Not known |
Face oedema | Common |
Fall | Uncommon |
Fatigue | Very Common |
Fever | Very Common |
Flatulence | Common |
Flu Syndrome | Common |
Fracture | Common |
Gait disturbance | Common |
Generalized oedema | Uncommon |
Gingivitis | Common |
Gynecomastia (Gynaecomastia) | Not known |
Hallucination | Not known |
Hepatitis | Not known |
Hyperglycaemia | Uncommon |
Hyperkinesia | Common |
Hypersensitivity | Not known |
Hypertension | Common |
Hypoesthesia | Common |
Hypoglycaemia | Rare |
Hypokinesia | Uncommon |
Hyponatraemia (Hyponatremia) | Not known |
Impotence | Common |
Increased appetite | Common |
Infection | Common |
Insomnia | Common |
Jaundice | Not known |
Leucopenia (Leukopenia) | Common |
Leukocyte count decreased (White blood cell count decreased) | Common |
Libido disorder | Not known |
Lightheadedness | Very Common |
Malaise | Common |
Mammary hypertrophy | Not known |
Mental impairment | Uncommon |
Muscle contractions involuntary | Common |
Myalgia | Common |
Myoclonus | Not known |
Nausea | Common |
Nervousness | Common |
Nystagmus | Common |
Oedema peripheral | Common |
Otitis media | Common |
Pain | Common |
Palpitations | Uncommon |
Pancreatitis | Not known |
Paraesthesia (paresthesia) | Common |
Pharyngitis | Common |
Pneumonia | Common |
Pruritus | Common |
Purpura | Common |
Reflexes absent | Common |
Reflexes decreased | Common |
Reflexes increased | Common |
Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute) | Not known |
Respiratory tract infection | Common |
Rhabdomyolysis | Not known |
Rhinitis | Common |
Skin Eruption | Common |
Somnolence | Very Common |
Stevens-Johnson syndrome | Not known |
Thought disturbances | Common |
Thrombocytopenia (Thrombopenia) | Not known |
Tinnitus | Not known |
Tooth disorder | Common |
Tremor | Common |
Urinary incontinence | Not known |
Urinary tract infection | Common |
Urticaria | Uncommon |
Vasodilation | Common |
Vertigo | Common |
Viral infection | Very Common |
Vomiting | Common |
Weight increased (weight gain) | Common |
Withdrawal syndrome | Not known |
Apo-Gabapentin :
NB : Products With Same Indication |
Different Units By MoH Code
Apo-Gabapentin MoH 6635 :
Form | Capsule, hard |
Packaging | Bottle |
Package Size | Box of 100 |
Strength | 300mg |
Storage Condition | 15-30°C Away from moisture |
Public Price | 2527767.74 L.L. |
Stratum | B |
NSSF | ✔ |
Quarantine | ✘ |
Reg. Number | 167485/10 |
Submission date | 01/01/2010 |
Registration Year | 2012 |
Barcode | 771313137942 |
Price Comparison
● Country: | Lebanon | |
● Form: | Capsule, hard | |
● Package Size: | Box of 100 | |
● Public Price: | 2527767.74 LBP | ( 2,527,767.74 LBP ) |
● Pack size unit used: | 100 | |
● Cost/Unit: | 25277,68 LBP | ( 25,277.00 LBP ) |
● Pricing Date: | 13/06/2024 |
● Country: | The Netherlands | |
● Package Size: | 100 | |
● Public Price: | 24.96 EUR | ( 2,418,024.96 LBP ) |
● Pack size unit used: | 100 | |
● Cost/Unit: | 0,2496 EUR | ( 0.00 LBP ) |
● Pharmacy Price: | 17.96 EUR | ( 1739892.96 LBP ) |
● Reference: | Zorginstituut Nederland | |
● Pricing Date: | 15/06/2019 | |
● Type: | Medicine Authorised |
● Country: | New Zealand |
● Package Size: | 100 cap |
● Exfactory Price: | 4.07 NZD |
● Reference: | New Zealand Pharmaceutical Management Agency |
● Pricing Date: | 01/04/2020 |
● Type: | Medicine Authorised |
Note
● Cost/Unit: | 25277,68 LBP | ( 25,277.00 LBP ) |
● Cost/Day: | 75833,04 LBP | ( 75,833.00 LBP ) |
● Cost/Month: | 2274991,2 LBP | ( 2,274,991.00 LBP ) |
● Cost/Unit: | 25277,68 LBP | ( 25,277.00 LBP ) |
● Cost/Day: | 75833,04 LBP | ( 75,833.00 LBP ) |
● Cost/Month: | 2274991,2 LBP | ( 2,274,991.00 LBP ) |
● Cost/Unit: | 25277,68 LBP | ( 25,277.00 LBP ) |
● Cost/Day: | 75833,04 LBP | ( 75,833.00 LBP ) |
● Cost/Month: | 2274991,2 LBP | ( 2,274,991.00 LBP ) |
● Cost/Unit: | 25277,68 LBP | ( 25,277.00 LBP ) |
● Cost/Day: | 75833,04 LBP | ( 75,833.00 LBP ) |
● Cost/Month: | 2274991,2 LBP | ( 2,274,991.00 LBP ) |
● Cost/Unit: | 0,2496 EUR | ( 0.00 LBP ) |
● Cost/Day: | 0,75 EUR | ( 0.00 LBP ) |
● Cost/Month: | 22,5 EUR | ( 2,131,272.00 LBP ) |
● Cost/Unit: | 0,2496 EUR | ( 0.00 LBP ) |
● Cost/Day: | 0,75 EUR | ( 0.00 LBP ) |
● Cost/Month: | 22,5 EUR | ( 2,131,272.00 LBP ) |
● Cost/Unit: | 0,2496 EUR | ( 0.00 LBP ) |
● Cost/Day: | 0,75 EUR | ( 0.00 LBP ) |
● Cost/Month: | 22,5 EUR | ( 2,131,272.00 LBP ) |
● Cost/Unit: | 0,2496 EUR | ( 0.00 LBP ) |
● Cost/Day: | 0,75 EUR | ( 0.00 LBP ) |
● Cost/Month: | 22,5 EUR | ( 2,131,272.00 LBP ) |
You have to register to view this info
Drop File